Systemic sclerosis (SSc) is an autoimmune disease of connective tissue characterized by fibrosis of the skin and internal organs, vascular damage, and immunological changes. One of the most severe complications is renal involvement, particularly scleroderma renal crisis (SRC). Renal crisis is one of the most serious complications of SSc and often occurs in diffuse SSc. This article discusses the pathogenesis, clinical manifestations, diagnostic methods, and modern approaches to treatment of renal involvement in SSc.

Systemic sclerosis, scleroderma renal crisis, chronic kidney disease

Bérezné A, Abdoul H, Karras A, Marie I, Huart A, Ficheux M, Queyrel V, Imbert B, Puéchal X, Hot A, Bienvenu B, Diot E, Moulin B, Quémeneur T, Kahn JE, Mouthon L, Guillevin for the French Vasculitis Study Group L. Bosentan in scleroderma renal crisis: a national open label prospective study [abstract]. Arthritis Rheumatol. 2017;69 (Suppl 10). https://acrabstracts.org/abstract/bosentan-in-scleroderma-renal-crisis-a-national-open-label-prospective-study/. Accessed 26 Feb 2021.

Butikofer L, Varisco PA, Distler O, Kowal-Bielecka O, Allanore Y, Riemekasten G, et al. ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis-a EUSTAR analysis. Arthritis Res Ther. 2020;22(1):59.

Denton CP, Lapadula G, Mouthon L, Muller-Ladner U. Renal complications and scleroderma renal crisis. Rheumatology (Oxford). 2009;48(Suppl 3): iii 32–5. Doctor NS,Shah AB, Coplan N, Kronzon I.Acute pericarditis. Prog Cardiovasc Dis 2017;59:349–59.

Foocharoen C, Peansukwech U, Mahakkanukrauh A et al. Clinical characteristics and outcomes of 566 H. Kim, F. Lefebvre, S. Hoa, M. Hudson. Mortality and morbidity in scleroderma renal crisis: A systematic literature review J Scleroderma Relat Disord, 6 (1) (2021 Feb), pp. 21-36, 10.1177/2397198320920422 [Epub 2020 Jun 1. PMID: 35382245; PMCID: PMC8922629]

Ida T, Ikeda K, Ohbe H et al. Early initiation of angiotensin-converting enzyme inhibitor in patients with scleroderma renal crisis: a nationwide inpatient database study. Rheumatology (Oxford) 2024;63:1507–11. Moinzadeh P, Kuhr K, Siegert E et al. Scleroderma renal crisis: risk factors for an increasingly rare organ complication. J Rheumatol 2020;47:241–8.

R. Sun, Q. Guo, J. Wang, et al. Central venous pressure and acute kidney injury in critically ill patients with multiple comorbidities: a large retrospective cohort study BMC Nephrol, 23 (2022), p. 83, 10.1186/s12882-022-02715-9

Sakchaikul A, Chowchuen P, Foocharoen C, Thammaroj P. Prevalence and clinical association with acroosteolysis in early systemic sclerosis. Clin Exp Rheumatol 2021; 39:1093-8.

Smith V, Herrick AL, Ingegnoli F, et al. Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud’s phenomenon and systemic sclerosis. Autoimmun Rev 2020; 19(3): 102458.

Stern EP, Unwin R, Burns A, Ong VH, Denton CP. Exploring molecular pathology of chronic kidney disease in systemic sclerosis by analysis of urinary and serum proteins. Rheumatol Adv Pract. 2021;5:rkaa083. https://doi.org/10.1093/rap/rkaa083.

Thais with systemic sclerosis: a cohort study. Int J Rheum Dis 2020;23:945–57.

Tsuji H, Kuramoto N, Sasai T et al. Autoantibody profiles associated with morbidity and mortality in scleroderma renal crisis. Rheumatology (Oxford) 2022;61:4130–5.

Zhou J, Hou Y, Wang Q et al. Clinical features and long-term outcomes of Chinese patients with scleroderma renal crisis. Int J Rheum Dis 2020;23:1194–200.